Search - tctmd.com

Displaying 1 - 20 of 62

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular News and Features for 2016

Shelley Wood

December 29, 2016

News Daily News

The Smartphone Will See You Now: Clinical Research Can Be Done via App

Yael L. Maxwell

December 16, 2016

News Daily News

Patients With A-fib Still Have High Mortality Risk After Appropriate Anticoagulation Is Started

Todd Neale

December 05, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2016

Shelley Wood

November 30, 2016

News Conference News AHA 2016

My Takeaways From AHA 2016: Too Late, Too Soon—Time Waits for No Trial

Shelley Wood

November 28, 2016

News Conference News AHA 2016

Statin-Associated Muscle Pain? It May Be Your Genes, Says GAUSS-3 Analysis

Michael O'Riordan

November 22, 2016

News Industry News

Two Differing Blood Clot Prevention Medications Used During Heart Procedure Are Both Safe and Effective for Patients, New Study Finds

November 21, 2016

News Conference News AHA 2016

Dabigatran Reversal Agent’s Safety, Efficacy Affirmed With Updated Study Results

Todd Neale

November 15, 2016

News Conference News AHA 2016

PCSK9 Inhibition and Other New Therapies for Lipid Modification: Good News and Bad

Michael O'Riordan

November 15, 2016

News Conference News AHA 2016

No CV Safety Differences for COX-2 Inhibitor vs Other NSAIDs in PRECISION

Shelley Wood

November 13, 2016

News Conference News AHA 2016

Ticagrelor Fails to Best Clopidogrel in Preventing CV Events in PAD Patients

Yael L. Maxwell

November 13, 2016

News Features

Run, Walk, Bike: Doctors Open Up About Their Own Heart-Healthy Exercise Habits

Michael O'Riordan

November 11, 2016

News Conference News AHA 2016

AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR

Shelley Wood

November 09, 2016

News Daily News

Pfizer Discontinues Investigational PCSK9 Inhibitor Bococizumab

Michael O'Riordan

November 01, 2016

Presentation TCT 2016

Improving Clinical Science: Priorities and Methods of Clinical Trials in Cardiovascular Regenerative Medicine

Presenter: Emerson C. Perin, Bernard J. Gersh

October 31, 2016

Presentation TCT 2016

Cells at the Moment of Truth: Findings From Meta-analysis and Systematic Reviews

Presenter: Emerson C. Perin, Mariann Gyöngyösi

October 31, 2016

Presentation TCT 2016

Beyond Cells: Cardiac Gene Therapy In Perspective

Presenter: Emerson C. Perin, Marc S. Penn

October 31, 2016

Presentation TCT 2016

New Sights from CHART -1 at 1 Year: Relationship of outcomes to baseline biomarkers and treatment intensity

Presenter: Emerson C. Perin, Jozef Bartunek

October 31, 2016

Presentation TCT 2016

Cells Alone Work: Lessons From Recent Clinical Trials

Presenter: Emerson C. Perin

October 31, 2016

Presentation TCT 2016

When Everything Has Disappeared: Role of Cell-Based Engineered Tissue and Organ Transplantation.

Presenter: Timothy D. Henry, Amit N. Patel, Doris A. Taylor

October 31, 2016

Advertisement

TCTMD’s Top 10 Most Popular News and Features for 2016

The Smartphone Will See You Now: Clinical Research Can Be Done via App

Patients With A-fib Still Have High Mortality Risk After Appropriate Anticoagulation Is Started

TCTMD’s Top 10 Most Popular Stories for November 2016

My Takeaways From AHA 2016: Too Late, Too Soon—Time Waits for No Trial

Statin-Associated Muscle Pain? It May Be Your Genes, Says GAUSS-3 Analysis

Two Differing Blood Clot Prevention Medications Used During Heart Procedure Are Both Safe and Effective for Patients, New Study Finds

Dabigatran Reversal Agent’s Safety, Efficacy Affirmed With Updated Study Results

PCSK9 Inhibition and Other New Therapies for Lipid Modification: Good News and Bad

No CV Safety Differences for COX-2 Inhibitor vs Other NSAIDs in PRECISION

Ticagrelor Fails to Best Clopidogrel in Preventing CV Events in PAD Patients

Run, Walk, Bike: Doctors Open Up About Their Own Heart-Healthy Exercise Habits

AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR

Pfizer Discontinues Investigational PCSK9 Inhibitor Bococizumab

Improving Clinical Science: Priorities and Methods of Clinical Trials in Cardiovascular Regenerative Medicine

Cells at the Moment of Truth: Findings From Meta-analysis and Systematic Reviews

Beyond Cells: Cardiac Gene Therapy In Perspective

New Sights from CHART -1 at 1 Year: Relationship of outcomes to baseline biomarkers and treatment intensity

Cells Alone Work: Lessons From Recent Clinical Trials

When Everything Has Disappeared: Role of Cell-Based Engineered Tissue and Organ Transplantation.

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content